Cognitive Behavioral Therapy in Treatment of Bipolar Disorder

Özdel, Kadir; Kart, Ayşegül

doi:10.29399/npa.27419

Cited by 10 publications

(8 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…CBT is recommended for the prevention of depressive or manic episodes and increasing treatment compliance of the pa-tients. Although studies have not reached the best point targeted in BD, CBT is one of the approaches that will provide the clearest contribution to the goal of relieving the suffering of patients and improving their lives [20]. Family therapy in BD will lower the patient's risk of recurrences and functional psychosocial impairment, improve health, and reduce and optimize socioeconomic resources [21].…”

Section: Discussionmentioning

confidence: 99%

Bipolar Disorder with Psychosis Featured in Patient with Systemic Lupus Erythematosus

Maulidianti,

Diatmika,

Wardani

2023

JPS

View full text Add to dashboard Cite

Abstracts Introductions: Bipolar disorder (BD) is a mental disorder that imposes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks, characterized by biphasic mood episodes of mania or hypomania and depression. More than half of all individuals diagnosed with BD experience psychosis features in their lifetime. The cause of BD is not entirely known, study claims that BD may occur due to or associated with autoimmune diseases. Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease with various physical manifestations, including neuropsychiatric features. Case: This case report will discuss a 22-year-old female with BD admitted to the emergency room due to solid psychosis features. The patient was diagnosed with SLE 3 years ago but never controlled prior to the disease history. The psychiatrist’s treatment in the emergency room was an extra injection of haloperidol 5 mg IM and diazepam 10 mg IM, continued with oral medication clozapine 25 mg two times a day and additional therapies such as cognitive behavioral therapy (CBT) and family therapy. The treatment from the internist was symptomatic medication due to the acute SLE symptoms, followed by autoimmune medicines such as steroids and hydroxychloroquine. Conclusions: BD may be associated with SLE. Psychosis features generally occur in BD, usually in the manic period. Treatment should be done for both psychiatric and internal medicine problems. As the SLE symptom was controlled, the BD symptom improved.

show abstract

Section: Discussionmentioning

confidence: 99%

Bipolar Disorder with Psychosis Featured in Patient with Systemic Lupus Erythematosus

Maulidianti,

Diatmika,

Wardani

2023

JPS

View full text Add to dashboard Cite

show abstract

“…Electroconvulsive therapy has been found to be effective in treating acute suicidality 82 . Although CBT has been shown to reduce suicidal behaviour in major depressive disorder, such effects are not established in bipolar disorder 102 .…”

Section: Suicidalitymentioning

confidence: 99%

The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management

et al. 2022

View full text Add to dashboard Cite

Bipolar disorder is heterogeneous in phenomenology, illness trajectory, and response to treatment. Despite evidence for the efficacy of multimodal ity interventions, the majority of persons affected by this disorder do not achieve and sustain full syndromal recovery. It is eagerly anticipated that combining datasets across various information sources (e.g., hierarchical "multiomic" measures, electronic health records), analyzed using ad vanced computational methods (e.g., machine learning), will inform future diagnosis and treatment selection. In the interim, identifying clinically meaningful subgroups of persons with the disorder having differential response to specific treatments at pointofcare is an empirical priority. This paper endeavours to synthesize salient domains in the clinical characterization of the adult patient with bipolar disorder, with the overarching aim to improve health outcomes by informing patient management and treatment considerations. Extant data indicate that characterizing select domains in bipolar disorder provides actionable information and guides shared decision making. For example, it is robustly established that the presence of mixed features -especially during depressive episodes -and of physical and psychiatric comorbidities informs illness trajectory, response to treatment, and suicide risk. In addition, early environmental exposures (e.g., sexual and physical abuse, emotional neglect) are highly associated with more complicated illness presentations, inviting the need for developmentallyoriented and integrated treatment approaches. There have been significant advances in validating subtypes of bipolar disorder (e.g., bipolar I vs. II disorder), particularly in regard to pharmacological interventions. As with other severe mental disorders, social functioning, interpersonal/family relationships and internalized stigma are domains highly relevant to relapse risk, health outcomes, and quality of life. The elevated standardized mortality ratio for completed suicide and suicidal behaviour in bipolar disorder invites the need for characterization of this domain in all patients. The framework of this paper is to describe all the above salient domains, provid ing a synthesis of extant literature and recommendations for decision support tools and clinical metrics that can be implemented at pointofcare.

show abstract

“…Multiple studies reported that the psychotherapeutic approach with close relatives, fellow or kin support, in addition to medication, improves cognitive performances and enhances self-dependency skills among BD cases [11,[114][115][116]. Psychological treatment options, especially cognitive behavioral therapy, are potentially effective in managing depressive events [117][118][119]. Several studies revealed that psychoeducation is more helpful among patients with manic symptoms of BD.…”

Section: Role Of Psychotherapy In Bipolar Mood Disordermentioning

confidence: 99%

Therapeutic Application of Lithium in Bipolar Disorders: A Brief Review

Kamal¹,

Dutta²,

Rahman³

et al. 2022

Cureus

View full text Add to dashboard Cite

Bipolar affective disorder includes Bipolar Disease (BD) and Bipolar Spectrum Disorder (BSD). The prevalence of BSD, BD-I, BD-II, and subthreshold BD globally is estimated to be about 3.1%, 1.5%,0.03%, and 1.6%, respectively. BD is a multidimensional disease that exhibits a range of moods of mania, hypomania, and depression. The disease is chronic, complex, and fatal, with a high possibility of reappearance, infirmity, social incompetence, and felo-de-se. Managing emotional disruption, negative neuropsychology, physiology, and immunology is a challenge. This review focuses on therapeutic benefits, adverse drug reactions, and pharmacological intervention for BD and BSD, in particular lithium. Long-term management of BD with a single medication is ineffective and therefore, not recommended. It is advised to use multiple agents for treatment instead. Medications include mood stabilizers (lithium and anticonvulsants), atypical antipsychotics, and antidepressants. Along with medication provision, psychotherapy is of great significance for BD patients. The review was conducted on recent available scientific literature through the electronic database like Embase, ScienceDirect, Google Scholar, and PubMed using keywords like ‘Bipolar Disease,’ ‘Bipolar Disease Therapeutics,’ ‘Bipolar Disease and Psychotherapy’ to highlight the possible effective means of management of this disease of mood instability.

show abstract

Cognitive Behavioral Therapy in Treatment of Bipolar Disorder

Cited by 10 publications

References 38 publications

Bipolar Disorder with Psychosis Featured in Patient with Systemic Lupus Erythematosus

Bipolar Disorder with Psychosis Featured in Patient with Systemic Lupus Erythematosus

The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management

Therapeutic Application of Lithium in Bipolar Disorders: A Brief Review

Contact Info

Product

Resources

About